p53 transcription factor is mutated in most skin cell carcinomas and in more than 50% of all human malignancies. One of its transcriptional targets is MDM2, which in turn down-regulates p53. The role of the p53/MDM2 regulatory loop upon genotoxic stress is well documented, but less is known about its role in normal tissue homeostasis. We have explored this pathway during the dierent transitions of the human epidermal dierentiation programme and after isolating stem cells, transit amplifying cells or dierentiating cells from epidermis. Maximum expression of p53 was found in proliferating keratinocytes. A striking and transient induction of MDM2 and a down-modulation of p53 characterized the transition from proliferation to dierentiation in primary human keratinocytes. These changes were delayed in late dierentiating carcinoma cells, and were clearly dierent in suspended primary ®broblasts. Interestingly, these changes correlated with an increase in cell size, at the time of irreversible commitment to dierentiation. Induction of MDM2 was also associated with suppression of proliferation in normal, or hyperproliferative, psoriatic epidermis. Moreover, both proteins were induced as keratinocytes were driven to leave the stem cell compartment by c-Myc activation. Overall, our results show a critical regulation of the p53/MDM2 pathway at the epidermal transition from proliferation to dierentiation.
Introduction
P53 is mutated or deleted in more than 50% of human tumours and in most skin carcinomas (reviewed in Basset-SeÂ guin et al., 1994; Sidransky and Hollstein, 1996) . Its protein product is activated by dierent cellular stresses, such as DNA damage, hypoxia, nucleoside depletion, spindle damage, or overexpression of oncogenic molecules (reviewed in May and May, 1999; Prives and Hall, 1999) . P53 transcription factor is considered as à genome guardian', since its activation protects the organism from tumorigenesis by inducing cell cycle arrest in G1 or G2/M, by controlling DNA replication and repair and/or by inducing apoptosis. p53 target genes include regulators of apoptosis and cell cycle, such as Bax/Redox genes, p21
Cip1 or MDM2, a direct modulator of p53. MDM2 interacts with p53, inhibits its transcriptional activity and provokes its degradation by the proteasome (reviewed and refs. in Piette et al., 1997; Freedman et al., 1999; Juven-Gershon and Oren, 1999) . Thus, overexpression of MDM2 during tumorigenesis may mimic p53 mutations in the process of cell transformation. In addition, MDM2 stimulates cell cycle progression and is able to transform cells in cooperation with other oncogenes. MDM2 binds and in¯uences the activity of cell cycle regulators E2F1 and Rb in a p53 independent manner.
Although the role of the p53/MDM2 pathway in protecting the organism from tumorigenesis is clearly established, its implication in normal development and tissue homeostasis is unclear (see Almog and Rotter, 1997) . A high proportion of p53 null mice are phenotypically normal but develop a high frequency of tumours and a few embryos die from developmental defects (reviewed in Almog and Rotter, 1997) . However, MDM2 null mouse embryos, which die at an early stage of development, are rescued when p53 alleles are additionally deleted (Montes-De Oca Luna et al., 1995; . These observations suggest that although the absence of p53 can be compensated for, its activity needs to be tightly controlled whenever it is present. Moreover, inactivation of p63, a homologue regulator of p53, results in important developmental defects, mainly in the strati®ed epithelia Mills et al., 1999) . A direct role of p53 in myoblast dierentiation has also been observed (Soddu et al., 1996) , and targeted expression of MDM2 inhibits mammary gland development (Lundgren et al., 1997) . We have made use of the human epidermis system in order to gain insights into the mechanisms by which p53 and MDM2 control normal proliferation and dierentiation.
Proliferation and dierentiation are compartmentalized within human epidermis (review in Watt, 1989; Fuchs and Byrne, 1994) . Keratinocytes proliferate in the basal layer as long as they are in contact with the extracellular matrix at the basement membrane (Watt and Green, 1981; Adams and Watt, 1989) . Proliferation is therefore controlled by integrins, the surface molecules that mediate cell adhesion (Watt and Jones, 1993) . As integrin function is disrupted, keratinocytes migrate into the suprabasal layers and initiate terminal dierentiation, enlarge, and ultimately, produce the corni®ed envelope that sheds from the surface of skin (Banks-Schlegel and Green, 1981; Watt and Green, 1981) . Within the basal layer keratinocytes can be in two distinct states: the stem cell and the transit amplifying cell (TAC). Stem cells have a great capacity for self renewal, but are thought to proliferate infrequently and be generally quiescent (Lavker and Sun, 1983; Hall and Watt, 1989) . As keratinocytes leave the stem cell compartment they enter a continuous but limited proliferative state (TAC) and, after a few rounds of cell divisions, initiate terminal dierentiation. The mechanisms that ensure that stem cells replicate correctly and commit TAC to terminal dierentiation are unknown.
Whereas the function of p53 in mediating UVinduced apoptosis in epidermal cells is well established (see e.g., Ziegler et al., 1994; Hall et al., 1993) , its role in the control of keratinocyte proliferation and dierentiation is less clear (reviewed in Gandarillas, 2000) . When overexpressed in organotypic cultures, p53 reduced keratinocyte proliferation and altered the normal dierentiation programme (Woodworth et al., 1993) . It is also able to induce some epidermal markers in carcinoma cells (Brenner et al., 1993) . In addition, p53 expression has been reported to be down-regulated in keratinocytes in response to calcium and TPA, concomitantly with an increase of activity (Weinberg et al., 1995; Kallassy et al., 1998) . Although p53 de®cient epidermal keratinocytes were unaected in their ability to dierentiate, they were aected in their growth control, and underwent malignant conversion more frequently during chemically-induced tumorigenesis (Weinberg et al., 1994 (Weinberg et al., , 1995 Kemp et al., 1993) . We have previously reported that MDM2 protein is expressed in living layers of human normal and in vitro reconstituted epidermis, weakly in basal cells, but with a signi®cant increase above the basal layer (Dazard et al., 1997) . We also found that the full length form of MDM2 protein is expressed in human cultured keratinocytes, regardless of the functional state of p53. These results suggested a possible role of MDM2 in epidermal dierentiation.
To study this issue further, and due to the limitations of experimenting with human epidermis in situ, we have explored the changes in the expression of the p53/MDM2 pathway during in vitro induced terminal dierentiation and in spontaneously dierentiating cultures. We further analysed the kinetics of expression of p53 and MDM2 during the sequential transitions of keratinocyte dierentiation. We did this by isolating epidermal stem cells, TAC and terminally dierentiating cells, and by activating c-Myc, an early keratinocyte dierentiation signal (Gandarillas and Watt, 1997) . Psoriatic epidermis was also used as an in vivo hyperproliferative model. We have found that p53 is down-regulated as stem cells lose their proliferative potential, whereas MDM2 expression is strikingly induced as TAC lose the cell cycle checkpoints, increase their cell size, and irreversibly commit to terminal dierentiation. Our results show for the ®rst time the precise temporal and spatial expression of p53 and MDM2 within human epidermal keratinocytes. They also provide novel insights into the role of the p53/MDM2 pathway in the maintenance of genome integrity and the control of tissue homeostasis.
Results

Kinetics of expression of p53 and MDM2 during suspension-induced keratinocyte differentiation
The pattern of expression of MDM2 in human epidermis (Dazard et al., 1997) prompted us to characterize the changes of expression of p53 and MDM2 during in vitro-induced keratinocyte terminal dierentiation. Human keratinocytes undergo terminal dierentiation within 24 h when placed in suspension in the absence of cell adhesion (Adams and Watt, 1989; Watt and Jones, 1993; Hotchin et al., 1995) . Using the DO-1 antibody on Western blotting, we found elevated levels of p53 in exponentially growing HEPK that were markedly decreased in suspension (Figure 1a ; see also Nigro et al., 1997) . In contrast, loss of anchorage provoked a striking and transient increase of MDM2 protein levels. These changes were detected after 6 h in suspension, at the time when keratinocytes lose their ability to proliferate and are irreversibly committed to terminal dierentiation (Adams and Watt, 1989; Hotchin and Watt, 1992) . Lysates obtained from cells before or after trypsin treatment showed no signi®cant dierences (not shown). Both proteins were barely detectable after 24 h ( Figure 1a ). The loss of p53 might be due to the ability of MDM2 to rapidly induce its proteolytic degradation (see Introduction).
We used two dierent parameters to monitor dierentiation: (i) the changes in cell size and morphology that occur during keratinocyte dierentiation and can be estimated by light scatter (Side Scatter/ Forward Scatter) in¯ow cytometry analyses (Jones and Watt, 1993) ; (ii) the expression of involucrin, an early terminal dierentiation marker and a precursor of the corni®ed envelope assembly, that can be detected bȳ ow cytometry or immunoblotting. During suspensioninduced terminal dierentiation (TD) of HEPK, the majority of cells become involucrin positive within 24 h (66.2%, not shown; see also Adams and Watt, 1989) . This detection of involucrin starts to be reduced after 24 h, when it is cross-linked into the corni®ed envelope ( Figure 1b , and note the upper bands of involucrin after 24 h in Figure 1a ; see also Gandarillas et al., 1999) . As keratinocytes undergo terminal dierentiation, they increase progressively in cellular size (BanksSchlegel and Green, 1981; Watt and Green, 1981) , and this is well re¯ected by Side Scatter (SSC) (Jones and Watt, 1993; Gandarillas et al., in press;  Figure 1b) . Interestingly, the variations in p53 and MDM2 levels occurred concomitantly with changes in cellular size and initiation of terminal dierentiation (Figure 1b and not shown).
To monitor the transition from proliferation to dierentiation in suspension more precisely, we analysed the expression of cell cycle markers. As observed by others, (Harvat et al., 1998; Martinez et al., 1999; Di Cunto et al., 1998) , we found a downregulation of the proliferation marker cyclin A, and the cell cycle regulator Rb, as well as an induction of CDK inhibitors p21
Cip1 and p27 Kip1 (Figure 1c,d ), characteristic events of proliferation arrest. It is worth noting that these changes, as the induction of MDM2, occurred at the time of irreversible commitment to dierentiation (Adams and Watt, 1989; Hotchin and Watt, 1992) . To further investigate the correlation between the changes observed in the expression of p53 and MDM2 and the keratinocyte transition from proliferation to dierentiation, we used SCC12B2 cells. These cells are derived from a human facial squamous cell carcinoma (Rheinwald et al., 1983; Parkinson et al., 1983) and are defective in their ability to dierentiate, as manifested by a delayed TD in suspension Figure 2a,b) . It should be noted that only a small proportion of cells were positive for involucrin after 36 h, whereas a signi®cant proportion of cells (83.9%) had already displayed changes in size and complexity ( Figure 2b ). Thus, SCC12B2 cells have a signi®cant time lag between morphological changes and initiation of terminal dierentiation. Also in SCC12B2, loss of anchorage provoked a down-regulation of p53 and a marked induction of MDM2 after 6 h, but the expression of both proteins was much more sustained than in normal cells (compare Figures 1a and 2a) . Interestingly, the induction of MDM2 occurred concomitantly with dramatic changes in cellular size, before a major induction of involucrin expression was observed. Both p53 and MDM2 were barely detectable after 96 h, when a signi®cant proportion of cells were expressing involucrin (Figure 2b ). Thus the changes observed in p53 and MDM2 expression correlated with the onset of terminal dierentiation both in normal and carcinoma cells, suggesting they were not a non-speci®c response to experimental stress. To determine whether the induction of MDM2 in suspension was regulated by an increase of p53 activity we performed similar suspension studies on the HaCaT human cell line of immortalized, non-transformed keratinocytes (Boukamp et al., 1988) . HaCaT cells carry mutations in both alleles of p53 that render the protein transcriptionally inactive (Lehman et al., 1993; Datto et al., 1995) . These cells partially retain a late response to dierentiate in suspension (note in Figure  2c the increase of soluble involucrin and the modest presence of cross-linked, higher polypeptides). Possibly as a consequence of its altering mutations, p53 levels were high and sustained in HaCaT cells in suspension. In contrast, MDM2 was induced by 6 h, as observed in primary or carcinoma cells. The expression of MDM2 was markedly more sustained in HaCaT than in primary keratinocytes, more resembling that of carcinoma cells, also correlating with a late initiation of terminal dierentiation. Therefore the induction of MDM2 in keratinocytes appears not to require p53 transcriptional activity, and may be a response to loss of cell adhesion.
To further assess whether the above observations were speci®cally associated with the progression of the epidermal dierentiation programme, we performed similar suspension experiments with human dermal primary ®broblasts (HDFP). As many other cell types, primary ®broblasts eventually undergo apoptosis when continuously deprived of cell anchorage (reviewed in Meredith and Schwartz, 1997) . The pro®les of expression for p53 and MDM2 in HDPF are in striking contrast to those observed in HEPK or SCC12B2. A down-regulation of p53 was also detected after 6 h. However, MDM2 expression was not signi®cantly increased after 6 h, declined by 12 h and was induced after 24 h. A striking induction of p53 occurred by 36 h, when a large sub G1 peak of DNA content, characteristic of apoptosis, was detected (Figure 3a,b ). An induction of MDM2 preceded that of p53, and occurred when an increase of cellular size started to become evident (see 24 h, Figure 3b ). p53 and MDM2 expression during spontaneous keratinocyte differentiation Primary keratinocytes do not stratify when cultured in a de®ned serum-free low calcium medium (DKSFM) in the absence of a feeder layer but instead, they form a monolayer of basal-like proliferative cells (Hennings et al., 1980; Wille et al., 1984) . However, terminal dierentiation is not suppressed and a proportion of cells within this monolayer express involucrin and eventually shed into the culture medium (Drozdo and Pledger, 1993; Watt and Green, 1982;  Figure 4 ; unpublished results). We have made use of this culture system as a further model of dierentiation. Adherent, proliferating keratinocytes expressed high levels of both p53 and MDM2, which were undetectable in spontaneously dierentiating cells. Most spontaneously detached HEPK expressed high levels of involucrin ( Figure 4a ) and had a large cellular size (Figure 4b ). However, a proportion of adherent cells expressed involucrin and had a bigger size, markers of initiation of dierentiation (Figure 4b) . A majority of keratinocytes present in the culture medium had assembled a corni®ed envelope (not shown), indicating that they were at a late stage of terminal dierentiation.
Expression of MDM2 and proliferation markers in normal and psoriatic epidermis
We wanted to test whether a transient up-regulation of MDM2 was also tightly and physiologically associated with the loss of proliferative potential and initiation of terminal dierentiation in vivo. Psoriasis is characterized by an increased epidermal turnover, with thickening of the proliferative and dierentiated compartments (reviewed in McKay and Leigh, 1995) . Wild type p53 is hardly detectable in normal, non-irradiated epidermis (see e.g., Hall et al., 1993; Dazard et al., 1997) . The deregulation of p53 in psoriasis seems uncertain, since it has been found moderately up-regulated in Ki67 positive layers (e.g., Soini et al., 1994; Hannuksela-Svahn et al., 1999) or not found at all (MoleÁ s et al., 1993) .
Immuno¯uorescence staining of cryosections from 13 psoriatic human skin biopsies revealed a pattern of expression of MDM2 reminiscent of what was observed in normal epidermis (Figure 5a,b; Dazard et al., 1997) . In psoriasis, however, MDM2 expression increased several layers above the basal layer, so that its induction was signi®cantly delayed in comparison with normal epidermis. Immunostaining for K5, a keratin that is speci®cally expressed in proliferative keratinocytes, declined as MDM2 expression increased. As a further marker of proliferation, we stained serial sections for nuclear Ki67, which was extended in psoriasis to several suprabasal layers (compare Figure  5b with a). We could not detect p53 in this series of psoriasis cryosections when probed with a panel of speci®c antibodies (not shown).
Nevertheless, the increase of MDM2 protein expression in both psoriatic and normal epidermis occurred as keratinocytes left the proliferative compartment.
Expression of p53 and MDM2 in isolated stem cells, TAC or TDC
Within the proliferative, basal layer of epidermis, stem cells give rise to TAC, which initiate terminal dierentiation after a few rounds of proliferation when Gandarillas et al., in press ). To determine how the expression of p53 and MDM2 changed during this transition, we have isolated stem cells and transit amplifying cells (TAC) both from keratinocyte cultures and from human epidermis. Expression and function of keratinocyte integrins correlate with proliferative potential (Jones and Watt, 1993;  see Figure 6c ). Hence, it is possible to isolate stem cells, TAC or terminally dierentiating cells on basis of their ability to adhere to the extracellular matrix protein collagen.
To isolate stem cells, exponentially growing keratinocytes (HEPK) were allowed to adhere on type I or IV collagen for 15 min. Cells that did not adhere were replated for a further 50 min to sort TAC from non adherent TDC. Clonogenicity assays and immunoblotting for involucrin (Figure 6b ,c) or¯ow-cytometry staining (not shown), allowed us to monitor the eciency of the isolation. As an internal control, unfractionated cells were maintained in suspension for the length of the experiment, and showed no changes in p53 or MDM2 expression (not shown). We found p53 to be mainly expressed in stem cells, decreased in TAC and barely detectable in TDC (Figure 6b ). In contrast, whereas MDM2 was not detected in stem cells, it was markedly induced in TAC and still expressed in terminally dierentiating cells that were harvested after 50 min on collagen. However, it was greatly reduced in cells that did not adhere after 60 min (Figure 6b ), indicating that MDM2 expression peaks as TAC initiate terminal dierentiation and is suppressed at late stages of maturation. This is consistent with what was observed in suspension experiments and normal epidermis (Figures 1a and 5) .
Similar experiments were performed with keratinocytes that were freshly isolated from human epidermis (Figure 6d ). Once again, clonogenicity assays and involucrin staining con®rmed the eciency of the isolation and unfractionated cells served as control (Figure 6d and not shown) . Interestingly, and in contrast to the in vitro situation, p53 was more abundant in TAC than in stem cells. Some p53 was still detected in freshly isolated TDC. MDM2 followed the pattern observed in cultured cells, except for more elevated levels in TDC.
Kinetics of expression of p53 and MDM2 in primary keratinocytes after constitutive activation of c-Myc
Continuous activation of c-myc for 2 days is sucient to drive keratinocytes out of the stem cell compartment to become TAC (Gandarillas and Watt, 1997) . After 5 days these cells initiate terminal dierentiation, which is markedly increased thereafter. Interestingly, activation of c-MycER fusion protein by 4-OH-tamoxifen (OHT) produced a transient induction of both p53 and MDM2, that was detected after 6 h for p53 and after 12 h for MDM2 (Figure 7 ). The expression of both proteins peaked at around 48 h, and declined to levels close to the control by day 8. It must be noted that although activation of c-Myc for 8 days in keratinocytes favours dierentiation, proliferation is not completely suppressed (Gandarillas and Watt, 1997) . It is also interesting to note that continuous activation of c-Myc in keratinocytes results in an increased cell size that is detectable after 24 h and becomes more evident after 5 days (Gandarillas et al., in press ). These results are thus consistent with what was observed in isolated stem cells, TAC and TDC, and with the suspension experiments in which cells are forced to lose their cell adherence.
Discussion
A switch from p53 to MDM2 accompanies initiation of epidermal terminal differentiation
The p53/MDM2 regulatory loop plays an important role in the control of cell cycle and apoptosis, and therefore its deregulation contributes to carcinogenesis (see Introduction). However, little is understood as to its role in adult tissue homeostasis in the absence of exogenous stress. Our results show a tight regulation of the expression of these molecules during the transition from proliferation to terminal dierentiation of human primary keratinocytes. Consistent with our previously reported MDM2 staining in epidermis (Dazard et al., 1997) , we have now found an early up-regulation of MDM2 during suspension-induced terminal dierentiation. This increase was associated with a down-regulation of p53. Interestingly, both changes occurred after 6 h in suspension, at the time when keratinocytes irreversibly lose the ability to proliferate and are committed to terminal dierentiation (Adams and Watt, 1989; Hotchin and Watt, 1993 ). An early upregulation of MDM2 was also observed when skin carcinoma cells which have a delayed terminal dierentiation response, were placed in suspension. These changes were not an in vitro response to experimental stress since: (i) the expression of MDM2 and p53 was more sustained in carcinoma cells, correlating with the late initiation of terminal dierentiation in these cells; (ii) the regulation of these molecules was very dierent in primary ®broblasts, in which a moderate sustained expression of MDM2 shortly preceded a dramatic induction of p53, as they underwent apoptosis; (iii) the pattern of expression of MDM2 in normal and psoriatic epidermis indicates that its induction is physiologically and tightly associated with suppression of proliferation and initiation of terminal dierentiation.
MDM2 was not however restricted to terminally dierentiating cells in the epidermis. We observed a faint staining in basal cells, suggesting that MDM2 upregulation is an early event also in vivo (Dazard et al., 1997; Figure 5 ). Both in normal epidermis and psoriasis, MDM2 declined in super®cial layers. Consistently, we detected a signi®cant expression of MDM2, as well as p53, in proliferating monolayers of keratinocytes cultured in low calcium, but not in cells that had spontaneously detached and were at a late stage of terminal dierentiation. Wild type p53 is hardly detectable in normal epidermis (e.g., Hall et al., 1993; Dazard et al., 1997) , but it has been observed in basal cells of in vitro reconstituted epidermis (Woodworth et al., 1993) . Our suspension experiments suggest that MDM2 is induced in keratinocytes as a response to loss of cell adhesion. A down-regulation of p53 protein has been shown to correlate with an increase of its transcriptional activity on reporter constructs, as keratinocytes are induced to stratify upon TPA or a calcium boost (Weinberg et al., 1995; Kallassy et al., 1998) . However, in our experiments, MDM2 induction seems to be independent of p53, since it also occurred in immortalized HaCaT keratinocytes in suspension (see also Dazard et al., 1997) and these cells have no transcriptionally active p53 (Lehman et al., 1993; Datto et al., 1995) . Furthermore, Alkhalaf et al. (1999) have found that an MDM2 transgene aects the keratinocyte cell cycle in the absence of p53. Therefore, MDM2 may be induced independently of p53 as keratinocytes lose interaction with the extracellular matrix, and may play an important role in normal epidermal homeostasis, other than just controlling p53 activity.
Loss of p53 and transient induction of MDM2 both occur as basal keratinocytes lose their proliferative potential
Isolating the dierent proliferative compartments from stratifying cultures or from human epidermis, on basis of adhesiveness potential, allowed us to be more precise concerning the spatial expression of p53 and MDM2. In culture, p53 was signi®cantly expressed in stem cells, slightly decreased in TAC and absent from terminally dierentiating cells. Cultured stem cells expressed no detectable MDM2, which was mainly con®ned to TAC and down-regulated as they initiated terminal dierentiation. In contrast to the cultures, p53 levels were higher in TAC than in stem cells of epidermis, and MDM2 was strikingly up-regulated in dierentiating cells, as previously observed by staining. These dierences are consistent with the dierent turnover of the systems we studied. Stratifying cultures are stimulated to proliferate by serum and growth factors, and thus cultured stem cells are continuously proliferating (see e.g. Figure 6c ). However in vivo, stem cells are thought to remain generally quiescent (Lavker and Sun, 1983; Hall and Watt, 1989) . Terminal dierentiation takes weeks in vivo, compared to days in culture and accordingly, the changes observed in p53/MDM2 expression were accelerated in culture. Nevertheless, maximum expression of p53 consistently occurred as keratinocytes underwent proliferation, whereas MDM2 was consistently induced at the time and place when they lose the ability to proliferate and commit to dierentiate terminally (see Figure 8) .
The expression of p53 in proliferating keratinocytes and MDM2 in dierentiating cells was somewhat unexpected, considering their reported functions (see Introduction). However, our results may coherently re¯ect the keratinocyte physiological features. Within the basal layer, the balance between stem cells and TAC that have the capacity to proliferate must be tightly controlled to avoid genomic alterations. This control becomes unnecessary as TAC irreversibly commit to dierentiation. P53 is able to arrest cell cycle in G1 or G2/M until the checkpoint controls are completed (see e.g., May and May, 1999) . In keratinocytes, p53 may function not only to keep stem cells quiescent but also to ensure the correct control of cell cycle and cell division as keratinocytes proliferate.
Interestingly, a surveillance role for p53 during proliferation and in stem cell renewal has also been proposed elsewhere (Mosner and Deppert, 1994; Almog and Rotter, 1997; .
Induction of MDM2 precedes an increase of keratinocyte cell enlargement and endoreplication
Why is MDM2 induced at the onset of dierentiation? It is important here to emphasise that keratinocytes increase their cell size as they dierentiate, both in vivo and in culture, so that they may initiate dierentiation beyond a certain volume (Banks-Schlegel and Green, 1981; Watt and Green, 1981; Gandarillas et al., in press ). In our experiments, both in culture and in vivo, MDM2 induction shortly preceded an increase of cellular size, even in the absence of terminal dierentiation in carcinoma cells and in primary ®broblasts that underwent apoptosis. The dramatic early induction of MDM2 in keratinocytes may contribute to prevent dierentiating cells from p53-mediated apoptosis, thus allowing them to pursue the dierentiation programme. We have recently found that upon dierentiation, and as in other human systems (e.g., Homann, 1989) , keratinocytes continue DNA replication after cell division is suppressed (Gandarillas et al., in press ). As a consequence of this phenomenon, referred to as endoreplication, cell growth results not in proliferation, but rather in an increased cellular size and polyploidy. In fact, endoreplication allows a great increase of cell size in a variety of systems (e.g., Jack et al., 1990; Traas et al., 1998; Conlon and Ra, 1999) .
Endoreplication and cell enlargement is stimulated in keratinocytes by continuous activation of c-Myc (Gandarillas et al., in press), a known promoter of Figure 8 Proposed model for p53 and MDM2 regulation during the dierent transitions of the human epidermal dierentiation programme. Relationship between p53, MDM2, proliferative capacity, cellular size and dierentiation. Note that keratinocyte size correlates with terminal dierentiation (see Discussion). In vivo, it is only TAC that are thought to proliferate actively. Our results suggest that p53 and MDM2 may control the epidermal transition from proliferation to dierentiation. Figure is a modi®cation of Jones and Watt (1993) cell cycle progression and cellular growth (Grandori and Eisenman, 1997; Dang et al., 1999) . Continuous activity of c-Myc also results in increased cellular size and loss of the cell cycle control in other cell types when mitosis is impaired Johnston et al., 1999; Iritani and Eisenman, 1999) . Initially cMyc drives keratinocytes to leave the stem cell compartment and become TAC, which after several days lose the correct control of cell cycle and initiate the increase of cell size and terminal dierentiation (Gandarillas and Watt, 1997; Gandarillas et al., in press ). Interestingly, MDM2 was markedly up-regulated over 6 days after activation of c-Myc in keratinocytes. A moderate induction of p53 expression was also detected, possibly re¯ecting the ability of cMyc to induce p53 expression (Reisman et al., 1993; see also Oren, 1999) and/or the proliferative state of TAC.
Our model is therefore that MDM2 contributes to the defective cell cycle and cellular growth that result in cell enlargement when cell division is impaired. Our observations strongly support this model when considered alongside other lines of evidence: (a) the deregulation of the p53/p21
Cip1 pathway has been found to produce a defective cell cycle and polyploidy in leukemic cells and E1A/ras transformed embryo ®broblasts (Peled et al., 1996; Bulavin et al., 1999) ; (b) loss of p53 allows endoreplication after mitotic spindle inhibition in a variety of systems, whereas its presence is able to suppress it (Minn et al., 1996; Di Leonardo et al., 1997; Notterman et al., 1998; Casenghi et al., 1999) ; (c) MDM2 expression in transgenic mammary gland produced enlarged polyploid cells (Lundgren et al., 1997; Reinke et al., 1999) ; (d) overexpression of p53 target p21
Cip1 has been reported to block cell cycle in G2/M and cause endoreplication and polyploidy when Rb was not functional in a variety of mouse and human cells, including a human epidermoid carcinoma (Niculescu et al., 1998) . Consistently, we and others have found that p21
Cip1 is upregulated and Rb down-regulated during keratinocyte dierentiation (Figure 1c ; Harvat et al., 1998; Hauser et al., 1997; unpublished results) and MDM2 has the capacity to inhibit Rb (Xiao et al., 1995) .
A molecular switch controlling keratinocyte growth?
A role of p53/MDM2 in controlling the switch between proliferation and dierentiation (Figure 8 ) is also consistent with experiments performed in mouse. P53 null mouse keratinocytes respond normally to induction of dierentiation, but are altered in their response to cell cycle inhibition by TGF-b (Weinberg et al., 1995) . This suggests that whereas p53 is not required for keratinocyte dierentiation, its presence may be important for a correct cell cycle control. Consistently, papillomas induced in mouse p53 null epidermis progress more frequently to carcinomas than in the wild type tissue (Kemp et al., 1993) . In addition, MDM2 transgenic mice have a transient epidermal phenotype that is reminiscent of ichthiosys or psoriasis, hyperproliferative lesions with thickening of dierentiating layers (Alkhalaf et al., 1999) . Finally, knock out mice for p63, a negative regulator of p53, have a striking epidermal phenotype, consisting of a layer of scattered dierentiating-like keratinocytes Mills et al., 1999) . Only a truncated form of p63 that has a dominant negative activity over p53 has been detected in epidermis, in proliferative keratinocytes (DN-p63; Yang et al., 1998; Parsa et al., 1999) . Interestingly, we have found DN-p63 down-regulated in dierentiating suspended keratinocytes and restricted to proliferative TAC of epidermis (unpublished results).
In conclusion, the results presented here suggest an important role of p53 in ensuring that a correct coordination between cell cycle and cell division, and thus genome integrity, are maintained in epidermal basal keratinocytes. In contrast, MDM2 may contribute to sustain an active cell cycle and cellular growth as these cells lose their proliferative potential and initiate terminal dierentiation (Figure 8 ). This model would provide novel insights as to why inactivation of p53 contributes to carcinogenesis.
Materials and methods
Cell culture
Human primary keratinocytes (HEPK) and human dermal primary ®broblasts (HDPF) were freshly isolated from human neonatal foreskin specimens as previously described (Laktionov et al., 1999) . Primary keratinocytes were cultured as monolayers in`low calcium' de®ned keratinocyte serumfree medium (DKSFM; 0.09 mM calcium; Gibco, Grand Island, NY, USA) supplemented with 15 ng/ml mouse submaxillary EGF (Sigma, St Louis, MO, USA). To allow proliferation and strati®cation, passages 2 ± 5 of strains KA, KQ, KMB of primary keratinocytes were cultured in FAD medium in the presence of a feeder layer of mouse ®broblasts as previously described (Rheinwald, 1989) .
Primary ®broblasts were cultured in DMEM containing 10% Donor Calf Serum (DCS). Human carcinoma SCC12B2 cells derived from a human facial squamous carcinoma (Rheinwald and Beckett, 1980) and the spontaneously immortalized keratinocyte cell line HaCaT (passages 42 ± 45; Boukamp et al., 1988) were cultured in DMEM/10% foetal calf serum. SCC12B2 cells have a heterozygous p53 single mutation in codon 216 (Burns et al., 1993) . HaCaT cells carry mutations in both alleles of p53 (Lehman et al., 1993; Datto et al., 1995) . All cells were cultured in 5% CO 2 , at 378C. Suspension experiments were performed in 1.75% methyl cellulose as previously described . In all cases adherent cultures were compared with cells harvested by trypsin treatment (0 h in suspension experiments), without detecting signi®cant dierences in the expression of the molecules studied.
Antibodies and Western blotting
Two anti-MDM2 monoclonal antibodies were used: the IF2 clone (Oncogene, Cambridge, MA, USA) and the 2A10 hybridoma (Olson et al., 1993) , which recognize the aminocentral portion and the ®rst zinc ®nger of the protein, respectively. The DO-1 recognizes all forms of p53 (Novacastra, UK). Other antibodies were: monoclonal antikeratin K5, clone LH6 , polyclonal antiDNp63 N16 (Santa Cruz, Biotechnology, Inc., USA), monoclonal anti-Ki67 (Dako, Copenhagen, Denmark), polyclonal anti-Rb C15 (Santa Cruz, Biotechnology, Inc., USA), monoclonal anti-cyclin A C4710 clone (Sigma, St Louis, MO, USA), monoclonal anti-involucrin SY-5 clone (kind gift of F Watt; Hudson et al., 1992) , polyclonal anti-p21
Cip1 and antip27
Kip1 antibodies (Santa Cruz, Biotechnology, Inc., USA), polyclonal anti-GAPDH (rabbit antiserum made in JM Blanchard's laboratory). For Western blotting, cells were lysed in RIPA buer supplemented with protease inhibitors, vortexed and centrifuged at 15 000 g for 10 min. Supernatants were used for SDS ± PAGE electrophoresis (Laemmli, 1970) . Protein gels were of 8% (for MDM2, p53, involucrin, GAPDH and Rb) or 12% (for p21
Cip1 and p27
Kip1
) polyacrylamide. Equal amounts of proteins were added per lane and transferred to PVDF membranes (Millipore, Bedford, MA, USA). After blocking and incubating with Abs, blots were ®nally subjected to enhanced chemiluminescence substrate (LumiLight, Roche, Mannheim, Germany) following suppliers protocol.
Tissue samples, immunofluorescence and immunohistochemistry
Normal Human Epidermis (NHE) samples were obtained from healthy volunteers undergoing plastic surgery (n=16). Psoriatic Human Epidermis (PHE) samples were collected from patients with chronic stable plaque psoriasis (n=13). Biopsies were carried out after informed consent, either on the upper limbs or trunk at the Dermatological Department of HoÃ pital Saint Eloi, Montpellier, France. After surgical excision and histological examination, tissue samples were processed as in Dazard et al. (1997) .
IF studies were carried out on 7 mm-thick cryostat tissuesections. For IF detection experiments on tissue sections or on cell spreadings, specimens were ®xed in 3.7% formaldehyde PBS for 10 min, and permeabilized either in cold methanol for 5 min or in cold acetone for 20 s. All slides were saturated in PBS containing 10% FCS for 30 min at 378C before incubation with the primary antibody in 0.5% FCS-PBS. After washes with PBS, slides were incubated with uorescein-conjugated antibodies (Sigma, St Louis, MO, USA), washed again and mounted with antifading mounting medium (Vector Laboratories, Burlingame, CA, USA). Fluorescence was analysed on a DM RX¯uorescence microscope (Leica, Wetzlar, Germany) and Images were processed with AdobePhotoshop software.
Isolation of stem cells, TAC and TDC
To isolate the dierent proliferative keratinocyte compartments, we performed two dierent variations of Jones and Watt (1993) . Protocol A: whole populations of keratinocytes were plated on 100 mg/cm 2 Vitrogen (Collagen Corp., Palo Alto, USA)-coated Petri dishes (5610 6 cells in 4 ml per dish) and placed in a cell incubator for 10 ± 15 min. The medium was collected and replated as before, and placed in a cell incubator for a further 50 min. Stem cells, that had adhered after the ®rst incubation, were rinsed with 250 mM EDTA-PBS and harvested with trypsin. After the second 50 ± 60 min incubation, the medium was collected and spun for the TDC fraction, and adherent cells, that constituted the TAC population, were harvested as before. As a control an aliquote of the initial population remained in suspension for the duration of the experiment. 5610 6 cells were washed with PBS and frozen for protein extraction. 1000 or 2000 cells were plated for clonogenicity assays. 5610 5 cells were dried on coverslips for involucrin staining by immuno¯uorescence.
Protocol B: unfractionated populations were allowed to adhere for 10 min. Cells that attached were stem cells and the rest were collected as a mixture of TAC and TDC. Parallel aliquotes were allowed to adhere for 50 min. Attached cells were a mixture of stem cells and TAC and the non-attached were TDC. Otherwise cells were processed as for protocol A. This second protocol yielded a higher number of cells.
Two independent experiments were performed following protocol A for cultured keratinocytes. For cells freshly isolated from epidermis, ®ve independent experiments were performed with foreskins from ®ve individuals, two following protocol A and three following protocol B.
Flow cytometry
Trypsinised keratinocytes were ®xed in 1% paraformaldehyde for 5 min or in 70% ethanol for 30 min and stained for involucrin or DNA with propidium iodide as previously described (Gandarillas and Watt, 1997) . After staining, all cells were ®rmly resuspended and ®ltered through a 70 mm mesh, and then analysed by¯ow cytometry on a Becton Dickinson FACScan. 10 000 ± 50 000 events were gated and acquired in list mode for every sample.
Clonogenicity assays
For clonogenicity assays 1000 or 2000 keratinocytes were plated per well, in triplicate, in complete FAD medium and in the presence of a feeder layer. The medium was replaced every 2 or 3 days. After 14 days, cultures were ®xed with formaldehyde, stained with Rhodanile blue and stem cell colonies scored as previously described (Gandarillas and Watt, 1997) .
Continuous activation of c-Myc in primary keratinocytes
Primary keratinocytes expressing empty retroviral vector pBabe or pBabe containing conditional c-mycER (Littlewood et al., 1995) were obtained by retroviral infection as previously described (Gandarillas and Watt, 1997) and cultured as normal keratinocytes. Activation of conditional c-Myc was achieved by adding 100 nM 4-hydroxytamoxifen (variant Z; Research Biochemicals International) to the culture medium every 48 h for the lengths of time indicated.
